Invasive mucormycosis in patients with hemoblastosis in St.-Petersburg

Thirty four patients with mucormycosis in 10 hospitals of St. Petersburg were observed in 2004-2013. The most frequent underlying diseases of mucormycosis were acute leukoses (64%). In 100% of the patients mucormycosis developed as a nosocomial infection. The risk factors, etiology, basic clinical s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antibiotiki i himioterapiâ 2013, Vol.58 (7-8), p.23-29
Hauptverfasser:	Khostelidi, S N, Volkova, A G, Popova, M O, Bogomolova, T S, Kolbin, A S, Boĭchenko, É G, Podol'tseva, É I, Klimovich, A V, Belogurova, M B, Medvedeva, N V, Ziuzgin, I S, Zubarovskaia, L S, Vasil'eva, N V, Klimko, N N
Format:	Artikel
Sprache:	rus
Schlagworte:	Adolescent Adult Aged Antifungal Agents - therapeutic use Child Child, Preschool Cross Infection - complications Cross Infection - drug therapy Cross Infection - microbiology Cross Infection - mortality Female Humans Leukemia, Lymphocytic, Chronic, B-Cell - complications Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - microbiology Leukemia, Lymphocytic, Chronic, B-Cell - mortality Leukemia, Myeloid, Acute - complications Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - microbiology Leukemia, Myeloid, Acute - mortality Male Middle Aged Mucormycosis - complications Mucormycosis - drug therapy Mucormycosis - microbiology Mucormycosis - mortality Prospective Studies Rhizopus - drug effects Rhizopus - growth & development Rhizopus - isolation & purification Risk Factors Russia Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Thirty four patients with mucormycosis in 10 hospitals of St. Petersburg were observed in 2004-2013. The most frequent underlying diseases of mucormycosis were acute leukoses (64%). In 100% of the patients mucormycosis developed as a nosocomial infection. The risk factors, etiology, basic clinical signs and strategy in the treatment of mucormycosis were analyzed.
ISSN:	0235-2990